In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other high-yield dividend stocks. Dividend stocks have been investors’ favorites for a ...

As the U.S. stock market continues its upward trajectory ... Kaiser Permanente, and CVS Caremark. In the aggregate, these sponsors represent over 25 million Medicare Part D beneficiaries.

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...

Oklahoma Attorney General Gentner Drummond sued CVS Caremark Tuesday, alleging that the company is under reimbursing pharmacies for prescription drugs. A CVS store is pictured. (Photo by Lynne ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The institutional investor owned 7,630 shares of the pharmacy operator’s stock after selling 235 shares during the period. Brighton Jones LLC’s holdings in CVS Health were worth $342,000 as of ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from $51.00 to $55.00. The adjustment reflects the firm's expectation of an ...

Evercore ISI boosted their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Cantor Fitzgerald reissued ...

China may be about to burst Silicon Valley's AI bubble — and Wall Street is freaking out. U.S. tech stocks plunged on Monday, amid a wider market sell-off. The culprit: DeepSeek, a Chinese ...

U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Non-Cum. Perp. Pfd. Series K)-0.83% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L)-0.72% U.S. Bancorp Dep. Pfd ...